Reese Richardson
reeserichardson.blog
Actively hiring
Higher Education
3D Printing
Bioinformatics
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
This blog focuses on my personal thoughts and activities. To see my professional work, go to my ORCiD profile.I am a recent PhD working in metascience and computational biology at Northwestern University.
News
How much of Thermo Fisher's antibody data has been manipulated?
TL;DR: As of 3 June 2026, we have identified more than 450 images bearing signs of manipulation in verification data advertised by Thermo Fisher Scientific in its online primary antibodies catalog (+1 by Abcam). See the full repository of problematic imag
Read more
Report
A scientific paper will cost you around $800
depending strongly on who you are buying from, what the topic and preferred venue are and what authorship slot you want. For the uninitiated: paper mills are illicit organizations that sell services to boost an academic's publication profile. Although a p
Read more
Report
The world's laziest peer reviewer
Happy Peer Review Week! TLDR: To make my latest tumble down a deep rabbit hole marginally less bumpy, I downloaded 250K peer review documents for 35K articles in six open access journals published by BMC (an imprint of Springer Nature). As of September 23
Read more
Report
A do-or-die moment for the scientific enterprise
Today, our article "The entities enabling scientific fraud at scale are large, resilient, and growing rapidly" was published in PNAS. The article will only be fully open-access in six months EDIT: 5 August, 2025: the article is now fully open-acess! View
Read more
Report
No, mRNA vaccines do not cause "transcriptomic chaos"
I have lots of to-do items on my plate lately, so naturally I have been distracted by the latest anti-vaccine bullshit. The regular crowd is abuzz with the news of a new study preprinted on preprints.org, a platform owned by MDPI. The preprint, posted 25
Read more
Report
Pro access
Upgrade to see all 13 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.